The use of hydroxyethyl starch for acute volume resuscitation in critically ill patients is associated with serious safety concerns, according to the authors of a recent paper published in the Journal ...

Intravenous use of hydroxyethyl starch to increase blood volume and revive critically ill patients is not only not associated with decreased mortality but, when questionable research is excluded from ...

There are currently 4 FDA-approved hydroxyethyl starch products on the market. The Food and Drug Administration (FDA) is requiring that the Boxed Warning for hydroxyethyl starch products be amended to ...

High-molecular-weight hydroxyethyl starches (hetastarches) can cause acquired type I von Willebrand's disease. 1 A case has also occurred after treatment with medium-molecular-weight hydroxyethyl ...

In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch was associated with adverse outcomes. An ...

Clinicians should not use hydroxyethyl starch (HES) solution in critically ill patients, including those with sepsis and those admitted to the intensive care unit, the US Food and Drug Administration ...

The increased risk of kidney injury related to the use of hydroxyethyl starch in resuscitation fluids reflects the mass of HES molecules, according to a report. Hydroxyethyl starch is a starch ...

1. Gattas D, Dan A, Myburgh J, et al.: Fluid resuscitation with 6% Hydroxyethyl Starch (130/0,4) in acutely ill patients: An updated systematic review and meta-analysis. Anesth Analg 2012; 114: 159–69 ...

Oscar Sevilla (Gobernacion De Antioquia-Indeportes Antiquia) has been handed a six month suspension by the Spanish Cycling Federation for his Hydroxyethyl Starch (HES) positive that occurred in last ...